Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）

NCT02188082 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Systolic Heart Failure

Interventions

DRUG: IvabRadine hemisulfate Sustained-release Tablets
DRUG: placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.